{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:00:04Z","timestamp":1791486004200,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"College of Health and Medicine"},{"name":"Select Foundation"},{"DOI":"10.13039\/501100001169","name":"Cancer Council Tasmania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001169","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001249","name":"University of Tasmania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001249","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The mitochondrion is an essential cell organelle known as the powerhouse of the cell. Mitochondrial ribosomal proteins (MRPs) are nuclear encoded, synthesised in the cytoplasm but perform their main functions in the mitochondria, which includes translation, transcription, cell death and maintenance. However, MRPs have also been implicated in cancer, particularly advanced disease and metastasis across a broad range of cancer types, where they play a central role in cell survival and progression. For some, their altered expression has been investigated as potential prognostic markers, and\/or therapeutic targets, which is the focus of this review. Several therapies targeting MRPs are currently approved by the Food and Drug Administration and the European Medicines Agency for use in other diseases, revealing the opportunity for repurposing their use in advanced and metastatic cancer. Herein, we review the evidence supporting key MRPs as molecular drivers of advanced disease in multiple cancer types. We also highlight promising avenues for future use of MRPs as precision targets in the treatment of late-stage cancers for which there are currently very limited effective treatment options.<\/jats:p>","DOI":"10.1007\/s10555-024-10216-4","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T15:02:02Z","timestamp":1727794922000},"page":"1119-1135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mitochondrial ribosomal proteins in metastasis and their potential use as prognostic and therapeutic targets"],"prefix":"10.1007","volume":"43","author":[{"given":"Jasmine M.","family":"Bacon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guei-Sheung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne L.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-6820","authenticated-orcid":false,"given":"Kelsie","family":"Raspin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"issue":"5","key":"10216_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41580-018-0092-0","volume":"20","author":"N Pfanner","year":"2019","unstructured":"Pfanner, N., Warscheid, B., & Wiedemann, N. (2019). Mitochondrial proteins: From biogenesis to functional networks. Nature Review Molecular Cell Biology, 20(5), 267\u2013284. https:\/\/doi.org\/10.1038\/s41580-018-0092-0","journal-title":"Nature Review Molecular Cell Biology"},{"issue":"6230","key":"10216_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.aaa1193","volume":"348","author":"A Amunts","year":"2015","unstructured":"Amunts, A., Brown, A., Toots, J., Scheres, S. H. W., & Ramakrishnan, V. (2015). The structure of the human mitochondrial ribosome. Science, 348(6230), 95\u201398. https:\/\/doi.org\/10.1126\/science.aaa1193","journal-title":"Science"},{"issue":"1","key":"10216_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-biochem-060815-014343","volume":"85","author":"BJ Greber","year":"2016","unstructured":"Greber, B. J., & Ban, N. (2016). Structure and Function of the Mitochondrial Ribosome. Annual Review of Biochemistry, 85(1), 103\u2013132. https:\/\/doi.org\/10.1146\/annurev-biochem-060815-014343","journal-title":"Annual Review of Biochemistry"},{"issue":"8","key":"10216_CR4","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.3390\/ijms22083827","volume":"22","author":"MIG Lopez Sanchez","year":"2021","unstructured":"Lopez Sanchez, M. I. G., Kr\u00fcger, A., Shiriaev, D. I., Liu, Y., & Rorbach, J. (2021). Human Mitoribosome Biogenesis and Its Emerging Links to Disease. International Journal of Molecular Sciences, 22(8), 3827. https:\/\/doi.org\/10.3390\/ijms22083827","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10216_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.gim.0000117333.21213.17","volume":"6","author":"JE Sylvester","year":"2004","unstructured":"Sylvester, J. E., Fischel-Ghodsian, N., Mougey, E. B., & O\u2019Brien, T. W. (2004). Mitochondrial ribosomal proteins: Candidate genes for mitochondrial disease. Genetics in Medicine, 6(2), 73\u201380. https:\/\/doi.org\/10.1097\/01.gim.0000117333.21213.17","journal-title":"Genetics in Medicine"},{"issue":"1\u20132","key":"10216_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/s0014-5793(01)02250-5","volume":"492","author":"EC Koc","year":"2001","unstructured":"Koc, E. C., Ranasinghe, A., Burkhart, W., Blackburn, K., Koc, H., Moseley, A., & Spremulli, L. L. (2001). A new face on apoptosis: Death-associated protein 3 and PDCD9 are mitochondrial ribosomal proteins. FEBS Letters, 492(1\u20132), 166\u2013170. https:\/\/doi.org\/10.1016\/s0014-5793(01)02250-5","journal-title":"FEBS Letters"},{"key":"10216_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12935-015-0187-z","volume":"15","author":"U Wazir","year":"2015","unstructured":"Wazir, U., Orakzai, M. M., Khanzada, Z. S., Jiang, W. G., Sharma, A. K., Kasem, A., & Mokbel, K. (2015). The role of death-associated protein 3 in apoptosis, anoikis and human cancer. Cancer Cell International, 15, 39. https:\/\/doi.org\/10.1186\/s12935-015-0187-z","journal-title":"Cancer Cell International"},{"issue":"43","key":"10216_CR8","doi-asserted-by":"publisher","first-page":"44667","DOI":"10.1074\/jbc.m408101200","volume":"279","author":"T Miyazaki","year":"2004","unstructured":"Miyazaki, T., Shen, M., Fujikura, D., Tosa, N., Kim, H.-R., Kon, S., Uede, T., & Reed, J. C. (2004). Functional role of death-associated protein 3 (DAP3) in anoikis. Journal of Biological Chemistry, 279(43), 44667\u201344672. https:\/\/doi.org\/10.1074\/jbc.m408101200","journal-title":"Journal of Biological Chemistry"},{"issue":"15","key":"10216_CR9","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.1128\/mcb.25.15.6603-6616.2005","volume":"25","author":"YA Yoo","year":"2005","unstructured":"Yoo, Y. A., Kim, M. J., Park, J. K., Chung, Y. M., Lee, J. H., Chi, S.-G., Kim, J. S., & Yoo, Y. D. (2005). Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1. Molecular and Cellular Biology, 25(15), 6603\u20136616. https:\/\/doi.org\/10.1128\/mcb.25.15.6603-6616.2005","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"10216_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/jcb.21079","volume":"100","author":"Y-C Chen","year":"2007","unstructured":"Chen, Y.-C., Chang, M.-Y., Shiau, A.-L., Yo, Y.-T., & Wu, C.-L. (2007). Mitochondrial ribosomal protein S36 delays cell cycle progression in association with p53 modification and p21WAF1\/CIP1 expression. Journal of Cellular Biochemistry, 100(4), 981\u2013990. https:\/\/doi.org\/10.1002\/jcb.21079","journal-title":"Journal of Cellular Biochemistry"},{"issue":"5","key":"10216_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nsmb.3010","volume":"22","author":"X Zhang","year":"2015","unstructured":"Zhang, X., Gao, X., Coots, R. A., Conn, C. S., Liu, B., & Qian, S.-B. (2015). Translational control of the cytosolic stress response by mitochondrial ribosomal protein L18. Nature Structural and Molecular Biology, 22(5), 404\u2013410. https:\/\/doi.org\/10.1038\/nsmb.3010","journal-title":"Nature Structural and Molecular Biology"},{"issue":"11","key":"10216_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1089\/dna.2016.3271","volume":"35","author":"H-B Li","year":"2016","unstructured":"Li, H.-B., Wang, R.-X., Jiang, H.-B., Zhang, E.-D., Tan, J.-Q., Xu, H.-Z., Zhou, R.-R., & Xia, X.-B. (2016). Mitochondrial ribosomal protein L10 associates with cyclin B1\/Cdk1 activity and mitochondrial function. DNA and Cell Biology, 35(11), 680\u2013690. https:\/\/doi.org\/10.1089\/dna.2016.3271","journal-title":"DNA and Cell Biology"},{"issue":"44","key":"10216_CR13","doi-asserted-by":"publisher","first-page":"17921","DOI":"10.1073\/pnas.1108852108","volume":"108","author":"YV Surovtseva","year":"2011","unstructured":"Surovtseva, Y. V., Shutt, T. E., Cotney, J., Cimen, H., Chen, S. Y., Koc, E. C., & Shadel, G. S. (2011). Mitochondrial Ribosomal Protein L12 selectively associates with human mitochondrial RNA polymerase to activate transcription. Proceedings of the National Academy of Sciences, 108(44), 17921\u201317926. https:\/\/doi.org\/10.1073\/pnas.1108852108","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"17","key":"10216_CR14","doi-asserted-by":"publisher","first-page":"12610","DOI":"10.1074\/jbc.m700461200","volume":"282","author":"Z Wang","year":"2007","unstructured":"Wang, Z., Cotney, J., & Shadel, G. S. (2007). Human mitochondrial ribosomal protein MRPL12 interacts directly with mitochondrial RNA polymerase to modulate mitochondrial gene expression. Journal of Biological Chemistry, 282(17), 12610\u201312618. https:\/\/doi.org\/10.1074\/jbc.m700461200","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10216_CR15","doi-asserted-by":"publisher","first-page":"105244","DOI":"10.1016\/j.isci.2022.105244","volume":"25","author":"C-W Chang","year":"2022","unstructured":"Chang, C.-W., Wei, Z., Durell, S. R., Ma, L., Forgues, M., & Wang, X. W. (2022). A compendium of co-regulated mitoribosomal proteins in pan-cancer uncovers collateral defective events in tumor malignancy. iScience, 25(10), 105244. https:\/\/doi.org\/10.1016\/j.isci.2022.105244","journal-title":"iScience"},{"issue":"1\u20132","key":"10216_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10555-019-09794-5","volume":"38","author":"J Lu","year":"2019","unstructured":"Lu, J. (2019). The Warburg metabolism fuels tumor metastasis. Cancer and Metastasis Reviews, 38(1\u20132), 157\u2013164. https:\/\/doi.org\/10.1007\/s10555-019-09794-5","journal-title":"Cancer and Metastasis Reviews"},{"issue":"7511","key":"10216_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"The Cancer Genome Atlas Research Network","year":"2014","unstructured":"The Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543\u2013550. https:\/\/doi.org\/10.1038\/nature13385","journal-title":"Nature"},{"issue":"42","key":"10216_CR18","doi-asserted-by":"publisher","first-page":"71772","DOI":"10.18632\/oncotarget.17888","volume":"8","author":"Y Gao","year":"2017","unstructured":"Gao, Y., Li, F., Zhou, H., Yang, Y., Wu, R., Chen, Y., Li, W., Li, Y., Xu, X., Ke, C., & Pei, Z. (2017). Down-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis. Oncotarget, 8(42), 71772\u201371781. https:\/\/doi.org\/10.18632\/oncotarget.17888","journal-title":"Oncotarget"},{"issue":"1","key":"10216_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10549-020-05532-6","volume":"180","author":"E Kl\u00e6stad","year":"2020","unstructured":"Kl\u00e6stad, E., Opdahl, S., Engstr\u00f8m, M. J., Ytterhus, B., Wik, E., Bofin, A. M., & Valla, M. (2020). MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes. Breast Cancer Research and Treatment, 180(1), 73\u201386. https:\/\/doi.org\/10.1007\/s10549-020-05532-6","journal-title":"Breast Cancer Research and Treatment"},{"issue":"20","key":"10216_CR20","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1038\/s41388-021-01785-7","volume":"40","author":"L Liu","year":"2021","unstructured":"Liu, L., Zhang, X., Ding, H., Liu, X., Cao, D., Liu, Y., Liu, J., Lin, C., Zhang, N., Wang, G., Hou, J., Huang, B., Zhang, Y., & Lu, J. (2021). Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS. Oncogene, 40(20), 3548\u20133563. https:\/\/doi.org\/10.1038\/s41388-021-01785-7","journal-title":"Oncogene"},{"issue":"1","key":"10216_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1471-2164-7-268","volume":"7","author":"H Lyng","year":"2006","unstructured":"Lyng, H., Br\u00f8vig, R. S., Svendsrud, D. H., Holm, R., Kaalhus, O., Knutstad, K., Oksefjell, H., Sundf\u00f8r, K., Kristensen, G. B., & Stokke, T. (2006). Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics, 7(1), 268. https:\/\/doi.org\/10.1186\/1471-2164-7-268","journal-title":"BMC Genomics"},{"key":"10216_CR22","doi-asserted-by":"publisher","first-page":"145697","DOI":"10.1016\/j.gene.2021.145697","volume":"790","author":"RP Oviya","year":"2021","unstructured":"Oviya, R. P., Gopal, G., Shirley, S. S., Sridevi, V., Jayavelu, S., & Rajkumar, T. (2021). Mitochondrial ribosomal small subunit proteins (MRPS) MRPS6 and MRPS23 show dysregulation in breast cancer affecting tumorigenic cellular processes. Gene, 790, 145697. https:\/\/doi.org\/10.1016\/j.gene.2021.145697","journal-title":"Gene"},{"issue":"7","key":"10216_CR23","doi-asserted-by":"publisher","first-page":"101042831770912","DOI":"10.1177\/1010428317709127","volume":"39","author":"M Pu","year":"2017","unstructured":"Pu, M., Wang, J., Huang, Q., Zhao, G., Xia, C., Shang, R., Zhang, Z., Bian, Z., Yang, X., & Tao, K. (2017). High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes. Tumor Biology, 39(7), 101042831770912. https:\/\/doi.org\/10.1177\/1010428317709127","journal-title":"Tumor Biology"},{"issue":"40","key":"10216_CR24","doi-asserted-by":"publisher","first-page":"68730","DOI":"10.18632\/oncotarget.19612","volume":"8","author":"F Sotgia","year":"2017","unstructured":"Sotgia, F., Fiorillo, M., & Lisanti, M. P. (2017). Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics. Oncotarget, 8(40), 68730\u201368745. https:\/\/doi.org\/10.18632\/oncotarget.19612","journal-title":"Oncotarget"},{"issue":"8","key":"10216_CR25","doi-asserted-by":"publisher","first-page":"e24898","DOI":"10.1097\/md.0000000000024898","volume":"100","author":"X Qiu","year":"2021","unstructured":"Qiu, X., Guo, D., Du, J., Bai, Y., & Wang, F. (2021). A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate. Medicine (Baltimore), 100(8), e24898. https:\/\/doi.org\/10.1097\/md.0000000000024898","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10216_CR26","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1002\/cam4.3907","volume":"10","author":"H Xu","year":"2021","unstructured":"Xu, H., Zou, R., Li, F., Liu, J., Luan, N., Wang, S., & Zhu, L. (2021). MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer. Cancer Medicine, 10(11), 3655\u20133673. https:\/\/doi.org\/10.1002\/cam4.3907","journal-title":"Cancer Medicine"},{"key":"10216_CR27","doi-asserted-by":"publisher","unstructured":"Hertweck, K. L., Vikramdeo, K. S., Galeas, J. N., Marbut, S. M., Pramanik, P., Yunus, F., Singh, S., Singh, A. P., & Dasgupta, S. (2023). Clinicopathological significance of unraveling mitochondrial pathway alterations in non\u2010small\u2010cell lung cancer. The FASEB Journal, 37(7). https:\/\/doi.org\/10.1096\/fj.202201724rr","DOI":"10.1096\/fj.202201724rr"},{"issue":"16","key":"10216_CR28","doi-asserted-by":"publisher","first-page":"22150","DOI":"10.18632\/oncotarget.7905","volume":"7","author":"M Mints","year":"2016","unstructured":"Mints, M., Mushtaq, M., Iurchenko, N., Kovalevska, L., Stip, M. C., Budnikova, D., Andersson, S., Polischuk, L., Buchynska, L., & Kashuba, E. (2016). Mitochondrial ribosomal protein S18\u20132 is highly expressed in endometrial cancers along with free E2F1. Oncotarget, 7(16), 22150\u201322158. https:\/\/doi.org\/10.18632\/oncotarget.7905","journal-title":"Oncotarget"},{"key":"10216_CR29","doi-asserted-by":"publisher","unstructured":"Mushtaq, M., Jensen, L., Davidsson, S., Grygoruk, O. V., Andr\u00e9n, O., Kashuba, V., & Kashuba, E. (2018). The MRPS18\u20132 protein levels correlate with prostate tumor progression and it induces CXCR4-dependent migration of cancer cells. Scientific Reports, 8(1). https:\/\/doi.org\/10.1038\/s41598-018-20765-8","DOI":"10.1038\/s41598-018-20765-8"},{"issue":"6","key":"10216_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jb\/mvab004","volume":"169","author":"O Revathi Paramasivam","year":"2021","unstructured":"Revathi Paramasivam, O., Gopisetty, G., Subramani, J., & Thangarajan, R. (2021). Expression and affinity purification of recombinant mammalian mitochondrial ribosomal small subunit (MRPS) proteins and protein-protein interaction analysis indicate putative role in tumourigenic cellular processes. Journal of Biochemistry, 169(6), 675\u2013692. https:\/\/doi.org\/10.1093\/jb\/mvab004","journal-title":"Journal of Biochemistry"},{"issue":"1","key":"10216_CR31","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1038\/s41598-022-14724-7","volume":"12","author":"X Lin","year":"2022","unstructured":"Lin, X., Guo, L., Lin, X., Wang, Y., & Zhang, G. (2022). Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer. Scientific Reports, 12(1), 10658. https:\/\/doi.org\/10.1038\/s41598-022-14724-7","journal-title":"Scientific Reports"},{"key":"10216_CR32","doi-asserted-by":"publisher","unstructured":"Fan, X., Liu, L., Shi, Y., Guo, F., Wang, H., Zhao, X., Zhong, D., & Li, G. (2020). Integrated analysis of RNA-binding proteins in human colorectal cancer. World Journal of Surgical Oncology, 18(1). https:\/\/doi.org\/10.1186\/s12957-020-01995-5","DOI":"10.1186\/s12957-020-01995-5"},{"key":"10216_CR33","doi-asserted-by":"publisher","unstructured":"Yu, X., Zhang, Y., Xiong, S., McDaniel, J. M., Sun, C., Chau, G. P., Gencel-Augusto, J., Chachad, D., Morrissey, R. L., Rao, X., Wang, J., & Lozano, G. (2022). Omics analyses of a somatic Trp53R245W\/+ breast cancer model identify cooperating driver events activating PI3K\/AKT\/mTOR signaling. Proceedings of the National Academy of Sciences, 119(45). https:\/\/doi.org\/10.1073\/pnas.2210618119","DOI":"10.1073\/pnas.2210618119"},{"issue":"1","key":"10216_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jmii.2020.12.008","volume":"55","author":"S-W Huang","year":"2022","unstructured":"Huang, S.-W., Sun, M.-T., Lee, W.-S., Su, Y.-s, Lee, Y.-T., Chiang, M.-H., Wang, Y.-C., Yang, Y.-S., Tzeng, S.-C., Wu, T.-Y., Sun, J.-S., & Lin, F.-H. (2022). Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate \u2013 An example of breast cancer. Journal of Microbiology, Immunology and Infection, 55(1), 51\u201359. https:\/\/doi.org\/10.1016\/j.jmii.2020.12.008","journal-title":"Journal of Microbiology, Immunology and Infection"},{"issue":"2","key":"10216_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bbrc.2018.12.127","volume":"509","author":"B Hu","year":"2019","unstructured":"Hu, B., & Guo, Y. (2019). Inhibition of mitochondrial translation as a therapeutic strategy for human ovarian cancer to overcome chemoresistance. Biochemical and Biophysical Research Communications, 509(2), 373\u2013378. https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.127","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"10216_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/15216540310001626610","volume":"55","author":"TW O'Brien","year":"2003","unstructured":"O\u2019Brien, T. W. (2003). Properties of human mitochondrial ribosomes. IUBMB Life, 55(9), 505\u2013513. https:\/\/doi.org\/10.1080\/15216540310001626610","journal-title":"IUBMB Life"},{"key":"10216_CR37","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2147\/ott.S293085","volume":"14","author":"X Yang","year":"2021","unstructured":"Yang, X., Cheng, Y., Li, X., Zhou, J., Dong, Y., Shen, B., Zhao, L., & Wang, J. (2021). A novel transcription factor-based prognostic signature in endometrial cancer: Establishment and validation. OncoTargets and Therapy, 14, 2579\u20132598. https:\/\/doi.org\/10.2147\/ott.S293085","journal-title":"OncoTargets and Therapy"},{"issue":"24","key":"10216_CR38","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1038\/s41388-019-0756-z","volume":"38","author":"MJ Contreras-Z\u00e1rate","year":"2019","unstructured":"Contreras-Z\u00e1rate, M. J., Day, N. L., Ormond, D. R., Borges, V. F., Tobet, S., Gril, B., Steeg, P. S., & Cittelly, D. M. (2019). Estradiol induces BDNF\/TrkB signaling in triple-negative breast cancer to promote brain metastases. Oncogene, 38(24), 4685\u20134699. https:\/\/doi.org\/10.1038\/s41388-019-0756-z","journal-title":"Oncogene"},{"issue":"6","key":"10216_CR39","doi-asserted-by":"publisher","first-page":"e0178173","DOI":"10.1371\/journal.pone.0178173","volume":"12","author":"Y-F Tsai","year":"2017","unstructured":"Tsai, Y.-F., Tseng, L.-M., Hsu, C.-Y., Yang, M.-H., Chiu, J.-H., & Shyr, Y.-M. (2017). Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer. PLoS ONE, 12(6), e0178173. https:\/\/doi.org\/10.1371\/journal.pone.0178173","journal-title":"PLoS ONE"},{"issue":"7","key":"10216_CR40","doi-asserted-by":"publisher","first-page":"e102558","DOI":"10.1371\/journal.pone.0102558","volume":"9","author":"L Huth","year":"2014","unstructured":"Huth, L., Rose, M., Kloubert, V., Winkens, W., Schlensog, M., Hartmann, A., Kn\u00fcchel, R., & Dahl, E. (2014). BDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: A novel role in tumor suppression? PLoS ONE, 9(7), e102558. https:\/\/doi.org\/10.1371\/journal.pone.0102558","journal-title":"PLoS ONE"},{"key":"10216_CR41","doi-asserted-by":"publisher","first-page":"155270","DOI":"10.1016\/j.cyto.2020.155270","volume":"136","author":"V Serafim Junior","year":"2020","unstructured":"Serafim Junior, V., Fernandes, GMd. M., Oliveira-Cucolo, JGd., Pavarino, E. C., & Goloni-Bertollo, E. M. (2020). Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer. Cytokine, 136, 155270. https:\/\/doi.org\/10.1016\/j.cyto.2020.155270","journal-title":"Cytokine"},{"issue":"4","key":"10216_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1758834014530023","volume":"6","author":"E Paplomata","year":"2014","unstructured":"Paplomata, E., & O\u2019Regan, R. (2014). The PI3K\/AKT\/mTOR pathway in breast cancer: Targets, trials and biomarkers. Therapeutic Advances in Medical Oncology, 6(4), 154\u2013166. https:\/\/doi.org\/10.1177\/1758834014530023","journal-title":"Therapeutic Advances in Medical Oncology"},{"issue":"4","key":"10216_CR43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/cells8040375","volume":"8","author":"N Riobo-Del Galdo","year":"2019","unstructured":"Riobo-Del Galdo, N., Lara Montero, \u00c1., & Wertheimer, E. (2019). Role of hedgehog signaling in breast cancer: Pathogenesis and therapeutics. Cells, 8(4), 375. https:\/\/doi.org\/10.3390\/cells8040375","journal-title":"Cells"},{"issue":"7","key":"10216_CR44","doi-asserted-by":"publisher","first-page":"103597","DOI":"10.1016\/j.drudis.2023.103597","volume":"28","author":"DK Patel","year":"2023","unstructured":"Patel, D. K., Kesharwani, R., Verma, A., Al-Abbasi, F. A., Anwar, F., & Kumar, V. (2023). Scope of Wnt signaling in the precise diagnosis and treatment of breast cancer. Drug Discovery Today, 28(7), 103597. https:\/\/doi.org\/10.1016\/j.drudis.2023.103597","journal-title":"Drug Discovery Today"},{"issue":"21","key":"10216_CR45","doi-asserted-by":"publisher","first-page":"2200081","DOI":"10.1002\/pmic.202200081","volume":"22","author":"Q Fu","year":"2022","unstructured":"Fu, Q., Hong, R., Zhou, H., Li, Y., Liu, X., Gong, J., Wang, X., Chen, J., Ran, H., Wang, L., Li, F., & Yuan, J. (2022). Proteomics reveals MRPL4 as a high-risk factor and a potential diagnostic biomarker for prostate cancer. Proteomics, 22(21), 2200081. https:\/\/doi.org\/10.1002\/pmic.202200081","journal-title":"Proteomics"},{"issue":"11","key":"10216_CR46","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.18632\/aging.103336","volume":"12","author":"B \u00d3zsv\u00e1ri","year":"2020","unstructured":"\u00d3zsv\u00e1ri, B., Sotgia, F., & Lisanti, M. P. (2020). First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: Mitoriboscins and TPP compounds. Aging, 12(11), 10162\u201310179. https:\/\/doi.org\/10.18632\/aging.103336","journal-title":"Aging"},{"issue":"5","key":"10216_CR47","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/1759-7714.13052","volume":"10","author":"Z Liu","year":"2019","unstructured":"Liu, Z., Xu, S., Li, L., Zhong, X., Chen, C., Fan, Y., Shen, W., Zu, L., Xue, F., Wang, M., & Zhou, Q. (2019). Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential. Thoracic Cancer, 10(5), 1111\u20131128. https:\/\/doi.org\/10.1111\/1759-7714.13052","journal-title":"Thoracic Cancer"},{"issue":"1","key":"10216_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbrc.2018.04.186","volume":"501","author":"L Qi","year":"2018","unstructured":"Qi, L., & Ding, Y. (2018). Analysis of metastasis associated signal regulatory network in colorectal cancer. Biochemical and Biophysical Research Communications, 501(1), 113\u2013118. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.186","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10216_CR49","doi-asserted-by":"publisher","first-page":"154625","DOI":"10.1016\/j.prp.2023.154625","volume":"248","author":"X-Y Li","year":"2023","unstructured":"Li, X.-Y., He, X.-Y., Zhao, H., Qi, L., & Lu, J.-J. (2023). Identification of a novel therapeutic target for lung cancer: Mitochondrial ribosome protein L9. Pathology - Research and Practice, 248, 154625. https:\/\/doi.org\/10.1016\/j.prp.2023.154625","journal-title":"Pathology - Research and Practice"},{"key":"10216_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jare.2021.01.018","volume":"33","author":"B Tang","year":"2021","unstructured":"Tang, B., Zhu, J., Zhao, Z., Lu, C., Liu, S., Fang, S., Zheng, L., Zhang, N., Chen, M., Xu, M., Yu, R., & Ji, J. (2021). Diagnosis and prognosis models for hepatocellular carcinoma patient\u2019s management based on tumor mutation burden. Journal of Advanced Research, 33, 153\u2013165. https:\/\/doi.org\/10.1016\/j.jare.2021.01.018","journal-title":"Journal of Advanced Research"},{"key":"10216_CR51","doi-asserted-by":"publisher","unstructured":"Hu, Y., Liu, Y., Ma, C., & Ai, K. (2023). MRPL12 acts as a novel prognostic biomarker involved in immune cell infiltration and tumor progression of lung adenocarcinoma. International Journal of Molecular Sciences, 24(3). https:\/\/doi.org\/10.3390\/ijms24032762","DOI":"10.3390\/ijms24032762"},{"key":"10216_CR52","doi-asserted-by":"publisher","unstructured":"Liu, Y., Sun, H., Li, X., Liu, Q., Zhao, Y., Li, L., Xu, B., Hou, Y., & Jin, W. (2021). Identification of a three-RNA binding proteins (RBPs) signature predicting prognosis for breast cancer. Frontiers in Oncology, 11. https:\/\/doi.org\/10.3389\/fonc.2021.663556","DOI":"10.3389\/fonc.2021.663556"},{"key":"10216_CR53","doi-asserted-by":"publisher","first-page":"12255","DOI":"10.2147\/ott.s263998","volume":"13","author":"Z Tao","year":"2020","unstructured":"Tao, Z., Suo, H., Zhang, L., Jin, Z., Wang, Z., Wang, D., Wu, M., Peng, N., Zhao, Y., & Chen, B. (2020). MRPL13 is a prognostic cancer biomarker and correlates with immune infiltrates in breast cancer. OncoTargets and Therapy, 13, 12255\u201312268. https:\/\/doi.org\/10.2147\/ott.s263998","journal-title":"OncoTargets and Therapy"},{"key":"10216_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/1498924","volume":"2021","author":"H Ye","year":"2021","unstructured":"Ye, H., & Zhang, N. (2021). Identification of the upregulation of MRPL13 as a novel prognostic marker associated with overall survival time and immunotherapy response in breast cancer. Computational and Mathematical Methods in Medicine, 2021, 1\u201314. https:\/\/doi.org\/10.1155\/2021\/1498924","journal-title":"Computational and Mathematical Methods in Medicine"},{"key":"10216_CR55","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.2147\/cmar.s296038","volume":"13","author":"M Cai","year":"2021","unstructured":"Cai, M., Li, H., Chen, R., & Zhou, X. (2021). MRPL13 promotes tumor cell proliferation, migration and EMT process in breast cancer through the PI3K-AKT-mTOR pathway. Cancer Management and Research, 13, 2009\u20132024. https:\/\/doi.org\/10.2147\/cmar.s296038","journal-title":"Cancer Management and Research"},{"key":"10216_CR56","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.2147\/cmar.s316428","volume":"13","author":"C Jing","year":"2021","unstructured":"Jing, C., Fu, R., Wang, C., Li, X., & Zhang, W. (2021). MRPL13 act as a novel therapeutic target and could promote cell proliferation in non-small cell lung cancer. Cancer Management and Research, 13, 5535\u20135545. https:\/\/doi.org\/10.2147\/cmar.s316428","journal-title":"Cancer Management and Research"},{"issue":"19","key":"10216_CR57","doi-asserted-by":"publisher","first-page":"10640","DOI":"10.18632\/aging.205104","volume":"15","author":"X Zhong","year":"2023","unstructured":"Zhong, X., He, Z., Fan, Y., Yin, L., Hong, Z., Tong, Y., Bi, Q., & Zhu, S. (2023). Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma. Aging, 15(19), 10640\u201310680. https:\/\/doi.org\/10.18632\/aging.205104","journal-title":"Aging"},{"issue":"7","key":"10216_CR58","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.21037\/tlcr-23-306","volume":"12","author":"D Wei","year":"2023","unstructured":"Wei, D., Sun, D., Sirera, R., Afzal, M. Z., Leong, T. L., Li, X., & Wang, Y. (2023). Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma. Translational Lung Cancer Research, 12(7), 1517\u20131538. https:\/\/doi.org\/10.21037\/tlcr-23-306","journal-title":"Translational Lung Cancer Research"},{"issue":"19","key":"10216_CR59","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1158\/1078-0432.ccr-05-0585","volume":"11","author":"CJM Best","year":"2005","unstructured":"Best, C. J. M., Gillespie, J. W., Yi, Y., Chandramouli, G. V. R., Perlmutter, M. A., Gathright, Y., Erickson, H. S., Georgevich, L., Tangrea, M. A., Duray, P. H., Gonz\u00e1Lez, S., Velasco, A., Linehan, W. M., Matusik, R. J., Price, D. K., Figg, W. D., Emmert-Buck, M. R., & Chuaqui, R. F. (2005). Molecular alterations in primary prostate cancer after androgen ablation therapy. Clinical Cancer Research, 11(19), 6823\u20136834. https:\/\/doi.org\/10.1158\/1078-0432.ccr-05-0585","journal-title":"Clinical Cancer Research"},{"key":"10216_CR60","doi-asserted-by":"publisher","unstructured":"Hou, W., Chen, J., & Wang, Y. (2024). MRPL35 Induces Proliferation, Invasion, and Glutamine Metabolism in NSCLC Cells by Upregulating SLC7A5 Expression. The Clinical Respiratory Journal, 18(7). https:\/\/doi.org\/10.1111\/crj.13799","DOI":"10.1111\/crj.13799"},{"key":"10216_CR61","doi-asserted-by":"publisher","unstructured":"Zhao, C., Chen, L., Jin, Z., Liu, H., Ma, C., Zhou, H., Xu, L., Zhou, S., Shi, Y., Li, W., Chen, Y., Dou, C., & Wang. X. (2023). Knockdown of MRPL35 promotes cell apoptosis and inhibits cell proliferation in non-small-cell lung cancer. BMC Pulmonary Medicine, 23(1). https:\/\/doi.org\/10.1186\/s12890-023-02677-0","DOI":"10.1186\/s12890-023-02677-0"},{"issue":"5","key":"10216_CR62","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ajpath.2019.02.003","volume":"189","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Lu, P., Yan, L., Yang, L., Wang, Y., Chen, J., Dai, J., Li, Y., Kang, Z., Bai, T., Xi, Y., Xu, J., Sun, G., & Yang, T. (2019). MRPL35 is up-regulated in colorectal cancer and regulates colorectal cancer cell growth and apoptosis. The American Journal of Pathology, 189(5), 1105\u20131120. https:\/\/doi.org\/10.1016\/j.ajpath.2019.02.003","journal-title":"The American Journal of Pathology"},{"issue":"16","key":"10216_CR63","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3748\/wjg.v27.i16.1785","volume":"27","author":"L Yuan","year":"2021","unstructured":"Yuan, L., Li, J. X., Yang, Y., Chen, Y., Ma, T. T., Liang, S., Bu, Y., Yu, L., & Nan, Y. (2021). Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins. World Journal of Gastroenterology, 27(16), 1785\u20131804. https:\/\/doi.org\/10.3748\/wjg.v27.i16.1785","journal-title":"World Journal of Gastroenterology"},{"issue":"22","key":"10216_CR64","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3748\/wjg.v28.i22.2437","volume":"28","author":"L Yuan","year":"2022","unstructured":"Yuan, L., Yang, Y., Li, X., Zhou, X., Du, Y. H., Liu, W. J., Zhang, L., Yu, L., Ma, T. T., Li, J. X., Chen, Y., & Nan, Y. (2022). 18\u03b2-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells. World Journal of Gastroenterology, 28(22), 2437\u20132456. https:\/\/doi.org\/10.3748\/wjg.v28.i22.2437","journal-title":"World Journal of Gastroenterology"},{"key":"10216_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2249909","volume":"2022","author":"W Luo","year":"2022","unstructured":"Luo, W., Han, Y., Li, X., Liu, Z., Meng, P., & Wang, Y. (2022). Breast cancer prognosis prediction and immune pathway molecular analysis based on mitochondria-related genes. Genetics Research, 2022, 1\u201313. https:\/\/doi.org\/10.1155\/2022\/2249909","journal-title":"Genetics Research"},{"issue":"5","key":"10216_CR66","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1631\/jzus.b1000192","volume":"12","author":"Y Wang","year":"2011","unstructured":"Wang, Y., Dong, L., Cui, H., Shen, D.-H., Wang, Y., Chang, X.-H., Fu, T.-Y., Ye, X., & Yao, Y.-Y. (2011). Up-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior. Journal of Zhejiang University SCIENCE B, 12(5), 346\u2013356. https:\/\/doi.org\/10.1631\/jzus.b1000192","journal-title":"Journal of Zhejiang University SCIENCE B"},{"issue":"8","key":"10216_CR67","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.7150\/jca.52277","volume":"12","author":"W Jiang","year":"2021","unstructured":"Jiang, W., Zhang, C., Kang, Y., Yu, X., Pang, P., Li, G., & Feng, Y. (2021). MRPL42 is activated by YY1 to promote lung adenocarcinoma progression. Journal of Cancer, 12(8), 2403\u20132411. https:\/\/doi.org\/10.7150\/jca.52277","journal-title":"Journal of Cancer"},{"key":"10216_CR68","doi-asserted-by":"publisher","unstructured":"Lee, J., Seol, M.-Y., Jeong, S., Lee, C. R., Ku, C. R., Kang, S.-W., Jeong, J. J., Shin, D. Y., Nam, K.-H., Lee, E. J., Chung, W. Y., & Jo, Y. S. (2015). A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma. Medicine, 94(2). https:\/\/doi.org\/10.1097\/MD.0000000000000380","DOI":"10.1097\/MD.0000000000000380"},{"issue":"2","key":"10216_CR69","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10142-011-0210-y","volume":"11","author":"Y-W Chen","year":"2011","unstructured":"Chen, Y.-W., Chou, H.-C., Lyu, P.-C., Yin, H.-S., Huang, F.-L., Chang, W.-S.W., Fan, C.-Y., Tu, I. F., Lai, T.-C., Lin, S.-T., Lu, Y.-C., Wu, C.-L., Huang, S.-H., & Chan, H.-L. (2011). Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers. Functional and Integrative Genomics, 11(2), 225\u2013239. https:\/\/doi.org\/10.1007\/s10142-011-0210-y","journal-title":"Functional and Integrative Genomics"},{"key":"10216_CR70","doi-asserted-by":"publisher","unstructured":"Huang, Y., Chen, S., Qin, W., Wang, Y., Li, L., Li, Q., & Yuan, X. (2020). A novel RNA binding protein-related prognostic signature for hepatocellular carcinoma. Frontiers in Oncology, 10. https:\/\/doi.org\/10.3389\/fonc.2020.580513","DOI":"10.3389\/fonc.2020.580513"},{"key":"10216_CR71","doi-asserted-by":"publisher","first-page":"153303382110049","DOI":"10.1177\/15330338211004936","volume":"20","author":"M Wang","year":"2021","unstructured":"Wang, M., Jiang, F., Wei, K., Wang, J., Zhou, G., Wu, C., & Yin, G. (2021). Development and validation of a RNA binding protein-associated prognostic model for hepatocellular carcinoma. Technology in Cancer Research & Treatment, 20, 153303382110049. https:\/\/doi.org\/10.1177\/15330338211004936","journal-title":"Technology in Cancer Research & Treatment"},{"issue":"10","key":"10216_CR72","doi-asserted-by":"publisher","first-page":"e74386","DOI":"10.1371\/journal.pone.0074386","volume":"8","author":"N Jiang","year":"2013","unstructured":"Jiang, N., Zhu, S., Chen, J., Niu, Y., & Zhou, L. (2013). A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: A meta-analysis of 4,385 participants. PLoS ONE, 8(10), e74386. https:\/\/doi.org\/10.1371\/journal.pone.0074386","journal-title":"PLoS ONE"},{"issue":"3","key":"10216_CR73","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1172\/jci125228","volume":"129","author":"PP Seth","year":"2019","unstructured":"Seth, P. P., Tanowitz, M., & Bennett, C. F. (2019). Selective tissue targeting of synthetic nucleic acid drugs. Journal of Clinical Investigation, 129(3), 915\u2013925. https:\/\/doi.org\/10.1172\/jci125228","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10216_CR74","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni, J. A., Witzigmann, D., Thomson, S. B., Chen, S., Leavitt, B. R., Cullis, P. R., & Van Der Meel, R. (2021). The current landscape of nucleic acid therapeutics. Nature Nanotechnology, 16(6), 630\u2013643. https:\/\/doi.org\/10.1038\/s41565-021-00898-0","journal-title":"Nature Nanotechnology"},{"issue":"10","key":"10216_CR75","doi-asserted-by":"publisher","first-page":"e10866","DOI":"10.1016\/j.heliyon.2022.e10866","volume":"8","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Ma, G., Liu, J., Zheng, H., Huang, G., Song, Q., Pang, Z., & Du, J. (2022). SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment. Heliyon, 8(10), e10866. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10866","journal-title":"Heliyon"},{"issue":"6","key":"10216_CR76","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1007\/s13577-022-00775-5","volume":"35","author":"B Zhou","year":"2022","unstructured":"Zhou, B., Mai, Z., Ye, Y., Song, Y., Zhang, M., Yang, X., Xia, W., & Qiu, X. (2022). The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancer. Human Cell, 35(6), 1900\u20131911. https:\/\/doi.org\/10.1007\/s13577-022-00775-5","journal-title":"Human Cell"},{"issue":"3","key":"10216_CR77","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3978\/j.issn.2072-1439.2010.02.03.7","volume":"2","author":"D Xiao","year":"2010","unstructured":"Xiao, D., & He, J. (2010). Epithelial mesenchymal transition and lung cancer. Journal of Thoracic Disease, 2(3), 154\u2013159. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2010.02.03.7","journal-title":"Journal of Thoracic Disease"},{"issue":"9","key":"10216_CR78","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/cancers13092128","volume":"13","author":"K-H Ho","year":"2021","unstructured":"Ho, K.-H., Huang, T.-W., Liu, A.-J., Shih, C.-M., & Chen, K.-C. (2021). Cancer essential genes stratified lung adenocarcinoma patients with distinct survival outcomes and identified a subgroup from the terminal respiratory unit type with different proliferative signatures in multiple cohorts. Cancers, 13(9), 2128. https:\/\/doi.org\/10.3390\/cancers13092128","journal-title":"Cancers"},{"issue":"12","key":"10216_CR79","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/1878-0261.12571","volume":"13","author":"AR Halvorsen","year":"2019","unstructured":"Halvorsen, A. R., Ragle Aure, M., \u00d5jlert, \u00c5. K., Brustugun, O. T., Solberg, S., Nebdal, D., & Helland, \u00c5. (2019). Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC. Molecular Oncology, 13(12), 2604\u20132615. https:\/\/doi.org\/10.1002\/1878-0261.12571","journal-title":"Molecular Oncology"},{"issue":"19","key":"10216_CR80","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1158\/1078-0432.ccr-10-0199","volume":"16","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D., Yin, X., Hoadley, K. A., Liu, Y., Hayward, M. C., Cabanski, C. R., Muldrew, K., Miller, C. R., Randell, S. H., Socinski, M. A., Parsons, A. M., Funkhouser, W. K., Lee, C. B., Roberts, P. J., Thorne, L., Bernard, P. S., Perou, C. M., & Hayes, D. N. (2010). Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clinical Cancer Research, 16(19), 4864\u20134875. https:\/\/doi.org\/10.1158\/1078-0432.ccr-10-0199","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10216_CR81","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2010.04.017","volume":"296","author":"D Liu","year":"2010","unstructured":"Liu, D., Hu, J., Agorreta, J., Cesario, A., Zhang, Y., Harris, A. L., Gatter, K., & Pezzella, F. (2010). Tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates genes involved in cell cycle and metastases. Cancer Letters, 296(2), 194\u2013205. https:\/\/doi.org\/10.1016\/j.canlet.2010.04.017","journal-title":"Cancer Letters"},{"issue":"3","key":"10216_CR82","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti, M. V., & Locasale, J. W. (2016). The Warburg effect: How does it benefit cancer cells? Trends in Biochemical Sciences, 41(3), 211\u2013218. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001","journal-title":"Trends in Biochemical Sciences"},{"key":"10216_CR83","doi-asserted-by":"publisher","unstructured":"Roshanzamir, F., Robinson, J. L., Cook, D., Karimi-Jafari M. H., & Nielsen, J. (2022). Metastatic triple negative breast cancer adapts its metabolism to destination tissues while retaining key metabolic signatures. Proceedings of the National Academy of Sciences, 119(35). https:\/\/doi.org\/10.1073\/pnas.2205456119","DOI":"10.1073\/pnas.2205456119"},{"issue":"40","key":"10216_CR84","doi-asserted-by":"publisher","first-page":"67457","DOI":"10.18632\/oncotarget.19084","volume":"8","author":"B \u00d3zsv\u00e1ri","year":"2017","unstructured":"\u00d3zsv\u00e1ri, B., Fiorillo, M., Bonuccelli, G., Cappello, A. R., Frattaruolo, L., Sotgia, F., Trowbridge, R., Foster, R., & Lisanti, M. P. (2017). Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast. Oncotarget, 8(40), 67457\u201367472. https:\/\/doi.org\/10.18632\/oncotarget.19084","journal-title":"Oncotarget"},{"key":"10216_CR85","doi-asserted-by":"publisher","unstructured":"Echtenkamp, F. J., Ishida, R., Rivera-Marquez, G. M., Maisiak, M., Johnson, O. T., Shrimp, J. H., Sinha, A., Ralph, S. J., Nisbet, I., Cherukuri, M. K., Gestwicki, J. E., & Neckers, L. M. (2023). Mitoribosome sensitivity to HSP70 inhibition uncovers metabolic liabilities of castration-resistant prostate cancer. PNAS Nexus, 2(4). https:\/\/doi.org\/10.1093\/pnasnexus\/pgad115","DOI":"10.1093\/pnasnexus\/pgad115"},{"issue":"1","key":"10216_CR86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","volume":"1241","author":"ML Nelson","year":"2011","unstructured":"Nelson, M. L., & Levy, S. B. (2011). The history of the tetracyclines. Annals of the New York Academy of Sciences, 1241(1), 17\u201332. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06354.x","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10216_CR87","doi-asserted-by":"publisher","unstructured":"Skrti\u0107, M., Sriskanthadevan, S., Jhas, B., Gebbia, M., Wang, X., Wang, Z., Hurren, R., Jitkova, Y., Gronda, M., Maclean, N., Lai, C. K., Eberhard, Y., Bartoszko, J., Spagnuolo, P., Rutledge, A. C., Datti, A., Ketela, T., Moffat, J., Robinson, B. H., . . . Schimmer, A. D. (2011). Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell, 20(5), 674\u2013688. https:\/\/doi.org\/10.1016\/j.ccr.2011.10.015","DOI":"10.1016\/j.ccr.2011.10.015"},{"issue":"73","key":"10216_CR88","doi-asserted-by":"publisher","first-page":"33818","DOI":"10.18632\/oncotarget.26107","volume":"9","author":"M Protasoni","year":"2018","unstructured":"Protasoni, M., Kroon, A. M., & Taanman, J.-W. (2018). Mitochondria as oncotarget: A comparison between the tetracycline analogs doxycycline and COL-3. Oncotarget, 9(73), 33818\u201333831. https:\/\/doi.org\/10.18632\/oncotarget.26107","journal-title":"Oncotarget"},{"issue":"2","key":"10216_CR89","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2010.10.008","volume":"63","author":"C Richards","year":"2011","unstructured":"Richards, C., Pantanowitz, L., & Dezube, B. J. (2011). Antimicrobial and non-antimicrobial tetracyclines in human cancer trials. Pharmacological Research, 63(2), 151\u2013156. https:\/\/doi.org\/10.1016\/j.phrs.2010.10.008","journal-title":"Pharmacological Research"},{"key":"10216_CR90","doi-asserted-by":"publisher","first-page":"175949","DOI":"10.1016\/j.ejphar.2023.175949","volume":"956","author":"J Li","year":"2023","unstructured":"Li, J., Qin, Y., Zhao, C., Zhang, Z., & Zhou, Z. (2023). Tetracycline antibiotics: Potential anticancer drugs. European Journal of Pharmacology, 956, 175949. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175949","journal-title":"European Journal of Pharmacology"},{"key":"10216_CR91","doi-asserted-by":"publisher","unstructured":"Liu, L., Wang, F., Tong, Y., Li, L. F., Liu, Y., & Gao, W. Q. (2020). Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction. Cell Proliferation, 53(1). https:\/\/doi.org\/10.1111\/cpr.12718","DOI":"10.1111\/cpr.12718"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-024-10216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-024-10216-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-024-10216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T12:12:59Z","timestamp":1731327179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-024-10216-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10216"],"URL":"https:\/\/doi.org\/10.1007\/s10555-024-10216-4","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}